ArticleFrontiers in cardiovascular medicine2026
Clinical factors associated with 30-day heart failure readmission in patients with acute decompensated heart failure with preserved ejection fraction.
Article in Frontiers in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: In acute decompensated heart failure with preserved ejection fraction (ADHFpEF), residual congestion before discharge is closely related to early heart failure (HF) readmission. This study evaluated the clinical factors associated with 30-day HF readmission in patients with ADHFpEF. Methods: This single-center retrospective study included 312 adults discharged after hospitalization for ADHFpEF between January 2020 and December 2024. Clinical, laboratory, echocardiographic, medication, and follow-up data were obtained from the medical records. Factors associated with 30-day HF readmission were evaluated using univariable and multivariable logistic regression analyses. Medication adherence was assessed using the Chinese version of the Adherence to Refills and Medications Scale (ARMS-C). Sensitivity analyses addressed coronavirus disease 2019 (COVID-19)-related calendar periods and chronic obstructive pulmonary disease (COPD). Results: Thirty-day HF readmission occurred in 62 patients (19.9%). Adherence and sensitivity analyses were consistent with the primary findings. Conclusions: In patients with ADHFpEF, several clinical factors were associated with 30-day HF readmission. Identification of these factors may support early risk assessment and individualized post-discharge management.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.